BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17359295)

  • 21. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer.
    Pelloski CE; Palmer M; Chronowski GM; Jhingran A; Horton J; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):131-7. PubMed ID: 15850913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical impact of computed tomography-based image-guided brachytherapy for cervix cancer using the tandem-ring applicator - the Addenbrooke's experience.
    Tan LT; Coles CE; Hart C; Tait E
    Clin Oncol (R Coll Radiol); 2009 Apr; 21(3):175-82. PubMed ID: 19101130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy.
    Perez CA; Grigsby PW; Castro-Vita H; Lockett MA
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1275-88. PubMed ID: 7635767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and validation of a novel scoring system to predict the risk of uterine perforation during intracavitary brachytherapy for cervical cancer.
    M Parvath ES; John NO; Sathyamurthy A; Ramireddy JK; Ram TS
    J Gynecol Oncol; 2024 May; 35(3):e35. PubMed ID: 38178701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uterine perforation during intracavitary brachytherapy for carcinoma of the cervix.
    Prabhakar GS; Revannasiddaiah S; Susheela SP; Anbumani S
    BMJ Case Rep; 2012 Dec; 2012():. PubMed ID: 23239779
    [No Abstract]   [Full Text] [Related]  

  • 26. Uterine perforation during brachytherapy for cervical cancer: Complications, outcomes, and best practices for forward treatment planning and management.
    Small W; Kim YS; Joyce C; Surucu M; Leshyk M; Harkenrider MM; Potkul RK; Liotta M; Winder A; Altoos B
    Brachytherapy; 2021; 20(3):557-564. PubMed ID: 33741275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insufficiency fractures after pelvic radiation therapy for uterine cervical cancer: an analysis of subjects in a prospective multi-institutional trial, and cooperative study of the Japan Radiation Oncology Group (JAROG) and Japanese Radiation Oncology Study Group (JROSG).
    Tokumaru S; Toita T; Oguchi M; Ohno T; Kato S; Niibe Y; Kazumoto T; Kodaira T; Kataoka M; Shikama N; Kenjo M; Yamauchi C; Suzuki O; Sakurai H; Teshima T; Kagami Y; Nakano T; Hiraoka M; Mitsuhashi N; Kudo S
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):e195-200. PubMed ID: 22583605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaginal Dose Is Associated With Toxicity in Image Guided Tandem Ring or Ovoid-Based Brachytherapy.
    Susko M; Craciunescu O; Meltsner S; Yang Y; Steffey B; Cai J; Chino J
    Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1099-105. PubMed ID: 26883564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
    Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
    Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tandem application with transvaginal ultrasound guidance.
    Sahinler I; Cepni I; Oksuz DC; Cepni K; Koksal S; Koca A; Atkovar G; Okkan S
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):190-6. PubMed ID: 15093916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computed Tomography-Guided Interstitial Brachytherapy for Locally Advanced Cervical Cancer: Introduction of the Technique and a Comparison of Dosimetry With Conventional Intracavitary Brachytherapy.
    Liu ZS; Guo J; Zhao YZ; Lin X; Zhang BY; Zhang C; Wang HY; Yu L; Ren XJ; Wang TJ
    Int J Gynecol Cancer; 2017 May; 27(4):768-775. PubMed ID: 28267131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brachytherapy management of the retroverted uterus using ultrasound-guided implant applicator placement.
    Mayr NA; Montebello JF; Sorosky JI; Daugherty JS; Nguyen DL; Mardirossian G; Wang JZ; Edwards SM; Li W; Yuh WT
    Brachytherapy; 2005; 4(1):24-9. PubMed ID: 15737903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective study to assess the bladder distension effects on dosimetry in intracavitary brachytherapy of cervical cancer via computed tomography-assisted techniques.
    Sun LM; Huang HY; Huang EY; Wang CJ; Ko SF; Lin H; Song JC
    Radiother Oncol; 2005 Oct; 77(1):77-82. PubMed ID: 15885826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uterine perforation at the time of brachytherapy for the carcinoma of the uterine cervix.
    Matsuyama T; Tsukamoto N; Matsukuma K; Kamura T; Jingu K
    Gynecol Oncol; 1986 Feb; 23(2):205-11. PubMed ID: 3943763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Computed Tomography- and Magnetic Resonance Imaging-based Clinical Target Volume Contours at Brachytherapy for Cervical Cancer.
    Swanick CW; Castle KO; Vedam S; Munsell MF; Turner LM; Rauch GM; Jhingran A; Eifel PJ; Klopp AH
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(4):793-800. PubMed ID: 27788952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uterine perforation and its dosimetric implications in cervical cancer high-dose-rate brachytherapy.
    Bahadur YA; Eltaher MM; Hassouna AH; Attar MA; Constantinescu C
    J Contemp Brachytherapy; 2015 Feb; 7(1):41-7. PubMed ID: 25829936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Minimizing urinary bladder radiation dose during brachytherapy for carcinoma of the cervix using balloon inflation technique.
    Malaker K; Shukla V; D'Souza H; Weatherburn H
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):257-66. PubMed ID: 15629619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
    Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2).
    Toita T; Kato S; Niibe Y; Ohno T; Kazumoto T; Kodaira T; Kataoka M; Shikama N; Kenjo M; Tokumaru S; Yamauchi C; Suzuki O; Sakurai H; Numasaki H; Teshima T; Oguchi M; Kagami Y; Nakano T; Hiraoka M; Mitsuhashi N
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e49-56. PubMed ID: 21470794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between the treated volume, the GTV and the CTV at the time of brachytherapy and the histopathologic findings in 33 patients with operable cervix carcinoma.
    Muschitz S; Petrow P; Briot E; Petit C; De Crevoisier R; Duvillard P; Morice P; Haie-Meder C
    Radiother Oncol; 2004 Nov; 73(2):187-94. PubMed ID: 15542166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.